SCHEMBL19786037

SCHEMBL19786037

CC(Br)c1nc2ncc(Br)c(N(C)C)c2c(=O)n1-c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.36
CYP2C9 P11712 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ALDH1A1 P00352 4/20 0.36
CASP1 P29466 4/20 0.36
CASP7 P55210 4/20 0.36
HSD17B10 Q99714 3/20 0.36
PIK3CD O00329 12/20 0.35
MEN1 O00255 3/20 0.35
USP2 O75604 3/20 0.35
KMT2A Q03164 3/20 0.35
HIF1A Q16665 3/20 0.35
CYP3A4 P08684 2/20 0.35
AURKA O14965 1/20 0.34
PIK3R1 P27986 8/20 0.33
PIK3CA P42336 5/20 0.33
PIK3CB P42338 5/20 0.33
PIK3CG P48736 5/20 0.33
CYP2D6 P10635 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17718372 0.71 SMN1; SMN2 (0.47) CYP1A2CYP2C9SMN1; SMN2NPSR1ALDH1A1
SCHEMBL938243 0.68 PIK3CD (0.61) CYP1A2CYP2C9SMN1; SMN2NPSR1ALDH1A1
SCHEMBL22854757 0.68 PIK3CB (0.48) CYP1A2CYP2C9SMN1; SMN2NPSR1PIK3CD
SCHEMBL22854483 0.68 ALDH1A1 (0.53) SMN1; SMN2ALDH1A1HSD17B10TSHRHPGD
SCHEMBL22854676 0.67 PIK3CD (0.61) PIK3CDPIK3R1PIK3CAPIK3CBPIK3CG
SCHEMBL22854703 0.67 PIK3CG (0.55) PIK3CDPIK3R1PIK3CAPIK3CBPIK3CG
SCHEMBL17718358 0.66 PIK3CD (0.40) CYP1A2CYP2C9SMN1; SMN2NPSR1PIK3CD
SCHEMBL17718365 0.66 SMN1; SMN2 (0.47) CYP1A2CYP2C9SMN1; SMN2NPSR1ALDH1A1
SCHEMBL22854485 0.65 PIK3CD (0.55) PIK3CDPIK3R1PIK3CAPIK3CBPIK3CG
SCHEMBL22854488 0.64 PIK3CD (0.58) PIK3CDPIK3R1PIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018013213-A1 COMPOUNDS FOR REDUCING C-MYC IN C-MYC OVEREXPRESSING CANCERS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2018-01-18 WO disclosed